This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1997 Jun 19;336(25):1822-4.

doi: 10.1056/NEJM199706193362510.

Hematopoietic growth factors--not whether, but when and where

PMID: 9187075
DOI: 10.1056/NEJM199706193362510

Editorial

Hematopoietic growth factors--not whether, but when and where

D Hoelzer. N Engl J Med. 1997.

. 1997 Jun 19;336(25):1822-4.

doi: 10.1056/NEJM199706193362510.

Author

PMID: 9187075
DOI: 10.1056/NEJM199706193362510

No abstract available

PubMed Disclaimer

Comment on

Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia.
Hartmann LC, Tschetter LK, Habermann TM, Ebbert LP, Johnson PS, Mailliard JA, Levitt R, Suman VJ, Witzig TE, Wieand HS, Miller LL, Moertel CG. Hartmann LC, et al. N Engl J Med. 1997 Jun 19;336(25):1776-80. doi: 10.1056/NEJM199706193362502. N Engl J Med. 1997. PMID: 9187067 Clinical Trial.
Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.
Pui CH, Boyett JM, Hughes WT, Rivera GK, Hancock ML, Sandlund JT, Synold T, Relling MV, Ribeiro RC, Crist WM, Evans WE. Pui CH, et al. N Engl J Med. 1997 Jun 19;336(25):1781-7. doi: 10.1056/NEJM199706193362503. N Engl J Med. 1997. PMID: 9187068 Clinical Trial.

Similar articles

[Preventing and treating hematologic complications of anticancer chemotherapy: update on hematopoietic growth factors].
Spaëth D, Geoffrois L, Conroy T. Spaëth D, et al. Bull Cancer. 2000 Jan;87(1):93-6. Bull Cancer. 2000. PMID: 10673637 Review. French. No abstract available.
When the risk of febrile neutropenia is 20%, prophylactic colony-stimulating factor use is clinically effective, but is it cost-effective?
Adams JR, Angelotta C, Bennett CL. Adams JR, et al. J Clin Oncol. 2006 Jul 1;24(19):2975-7. doi: 10.1200/JCO.2006.05.6812. Epub 2006 May 8. J Clin Oncol. 2006. PMID: 16682722 No abstract available.
Granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia.
Welte K, Riehm H. Welte K, et al. N Engl J Med. 1997 Oct 30;337(18):1320; author reply 1321. N Engl J Med. 1997. PMID: 9380088 No abstract available.
Should the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended?
Klastersky J, Awada A, Aoun M, Paesmans M. Klastersky J, et al. Curr Opin Oncol. 2009 Jul;21(4):297-302. doi: 10.1097/CCO.0b013e32832c9651. Curr Opin Oncol. 2009. PMID: 19509500 Review.
Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.
Pui CH, Boyett JM, Hughes WT, Rivera GK, Hancock ML, Sandlund JT, Synold T, Relling MV, Ribeiro RC, Crist WM, Evans WE. Pui CH, et al. N Engl J Med. 1997 Jun 19;336(25):1781-7. doi: 10.1056/NEJM199706193362503. N Engl J Med. 1997. PMID: 9187068 Clinical Trial.

See all similar articles

Cited by

Close association between clearance of recombinant human granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor on neutrophils in cancer patients.
Terashi K, Oka M, Ohdo S, Furukubo T, Ikeda C, Fukuda M, Soda H, Higuchi S, Kohno S. Terashi K, et al. Antimicrob Agents Chemother. 1999 Jan;43(1):21-4. doi: 10.1128/AAC.43.1.21. Antimicrob Agents Chemother. 1999. PMID: 9869559 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.